Literature DB >> 22286000

TACE treatment in hepatocellular carcinoma: what should we do now?

Fabio Farinati, Anna Giacomin, Veronica Vanin, Edoardo Giannini, Franco Trevisani.   

Abstract

Entities:  

Year:  2012        PMID： 22286000     DOI： 10.1016/j.jhep.2011.12.022

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  12 in total

1.  Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma.

Authors:  Jia-Yan Ni; Shan-Shan Liu; Lin-Feng Xu; Hong-Liang Sun; Yao-Ting Chen
Journal:  World J Gastroenterol       Date:  2013-06-28       Impact factor: 5.742

2.  Transarterial embolization combined with RNA interference targeting hypoxia-inducible factor-1α for hepatocellular carcinoma: a preliminary study of rat model.

Authors:  Jia-Yan Ni; Lin-Feng Xu; Wei-Dong Wang; Qiao-Sheng Huang; Hong-Liang Sun; Yao-Ting Chen
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-16       Impact factor: 4.553

3.  Radiofrequency ablation or microwave ablation combined with transcatheter arterial chemoembolization in treatment of hepatocellular carcinoma by comparing with radiofrequency ablation alone.

Authors:  Yongxiang Yi; Yufeng Zhang; Qiang Wei; Liang Zhao; Jianbo Han; Yan Song; Ying Ding; Guilan Lu; Junmao Liu; Huaiying Ding; Feng Dai; Xiaojun Tang
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

Review 4.  Current systemic treatment of hepatocellular carcinoma: A review of the literature.

Authors:  Kai-Wen Chen; Tzu-Ming Ou; Chin-Wen Hsu; Chi-Ting Horng; Ching-Chang Lee; Yuh-Yuan Tsai; Chi-Chang Tsai; Yi-Sheng Liou; Chen-Chieh Yang; Chao-Wen Hsueh; Wu-Hsien Kuo
Journal:  World J Hepatol       Date:  2015-06-08

5.  Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival.

Authors:  Marco Biolato; Luca Miele; Vittoria Vero; Simona Racco; Carmine Di Stasi; Roberto Iezzi; Andrea Zanché; Maurizio Pompili; Gian Ludovico Rapaccini; Giuseppe La Torre; Antonio Gasbarrini; Antonio Grieco
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

6.  Chemoembolization of intermediate stage hepatocellular carcinomas: results from a Nordic tertiary liver cancer center.

Authors:  Kasper J Andersen; Henning Grønbaek; Gerda Elisabeth Villadsen; Anders Riegels Knudsen; Peter Ott; Hendrik Vildstrup; Dennis Tønner Nielsen; Arindam Bharadwaz
Journal:  Indian J Gastroenterol       Date:  2013-12-04

Review 7.  Patient Selection for Transarterial Chemoembolization in Hepatocellular Carcinoma: Importance of Benefit/Risk Assessment.

Authors:  Fabio Piscaglia; Sadahisa Ogasawara
Journal:  Liver Cancer       Date:  2018-01-12       Impact factor: 11.740

8.  Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas.

Authors:  Lin Zheng; Hai-Liang Li; Chen-Yang Guo; Su-Xia Luo
Journal:  Korean J Radiol       Date:  2018-02-22       Impact factor: 3.500

9.  The effects of patient cost sharing on inpatient utilization, cost, and outcome.

Authors:  Yuan Xu; Ning Li; Mingshan Lu; Elijah Dixon; Robert P Myers; Rachel J Jolley; Hude Quan
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

10.  Transarterial Chemoembolization and Sorafenib Combined with Microwave Ablation for Advanced Primary Hepatocellular Carcinoma: A Preliminary Investigation of Safety and Efficacy.

Authors:  Jia-Yan Ni; Hong-Liang Sun; Jiang-Hong Luo; Xiong-Ying Jiang; Dong Chen; Wei-Dong Wang; Yao-Ting Chen; Jin-Hua Huang; Lin-Feng Xu
Journal:  Cancer Manag Res       Date:  2019-11-26       Impact factor: 3.989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.